Медицинский совет (Dec 2016)
The role of sulfonylures in the treatment of type 2 diabetes
Abstract
Type 2 diabetes mellitus (T2DM) is one of the most common diseases in the world accounting for about 85--90% of the total number of people with diabetes. More than 80% of these patients are overweight or obese, and lead sedentary lifestyles. If earlier T2DM was considered "a disease of the elderly", now half of patients suffering from the disease are people of working age. Reduced working ability as well as financial burden of prevention and treatment of late complications of DM are a significant problem for the healthcare system and society as a whole. At the same time, T2DM therapy involving effective medicines which are convenient and have minimum side effects could markedly reduce treatment costs.
Keywords